Torrent alone grabbed 3 percent of the Rs 1,600-crore GLP-1 agonist market within days of its launch, in part because it was the only company to also offer an oral formulation
Moreover, semaglutide is evolving past just diabetes and weight loss, thus expanding into treatments for heart failure, chronic kidney disease, and metabolic dysfunction
A secondary analysis of a randomized clinical trial examined changes in BMD at clinically significant sites following an 8-week low-calorie diet (800 kcal/day) for weight loss, followed by a year-long treatment with liraglutide (3.0 mg daily), exercise alone (a supervised and progressive resistance training program), a combination of both treatments (liraglutide + exercise), or a placebo [74]
Do not start, stop, or change GLP-1 medications without guidance from a qualified clinician
#4 Introduce family-friendly options With most of the UKs GLP-1 shoppers living with partners and children, theres scope for product development thats both at home with individual GLP-1 users and their household members